Department of Infectious Disease, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Infections Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran.
Wound Repair Regen. 2019 May;27(3):277-284. doi: 10.1111/wrr.12701. Epub 2019 Feb 11.
This study was carried out to determine the effects of magnesium and vitamin E co-supplementation on wound healing and metabolic status in patients with diabetic foot ulcer (DFU). The current randomized, double-blind, placebo-controlled trial was conducted among 57 patients with grade 3 DFU. Participants were randomly divided into two groups to take either 250 mg magnesium oxide plus 400 IU vitamin E (n = 29) or placebo per day (n = 28) for 12 weeks. Compared with the placebo, taking magnesium plus vitamin E supplements reduced ulcer length (β [difference in the mean of outcomes measures between treatment groups] -0.56 cm; 95% CI, -0.92, -0.20; p = 0.003), width (β -0.35 cm; 95% CI, -0.64, -0.05; p = 0.02) and depth (β -0.18 cm; 95% CI, -0.33, -0.02; p = 0.02). In addition, co-supplementation led to a significant reduction in fasting plasma glucose (β -13.41 mg/dL; 95% CI, -20.96, -5.86; p = 0.001), insulin (β -1.45 μIU/ml; 95% CI, -2.37, -0.52; p = 0.003), insulin resistance (β -0.60; 95% CI, -0.99, -0.20; p = 0.003) and HbA1c (β -0.32%; 95% CI, -0.48, -0.16; p < 0.003), and a significant elevation in insulin sensitivity (β 0.007; 95% CI, 0.003, 0.01; p < 0.001) compared with the placebo. Additionally, compared with the placebo, taking magnesium plus vitamin E supplements decreased triglycerides (β -10.08 mg/dL; 95% CI, -19.70, -0.46; p = 0.04), LDL-cholesterol (β -5.88 mg/dL; 95% CI, -11.42, -0.34; p = 0.03), high sensitivity C-reactive protein (hs-CRP) (β -3.42 mg/L; 95% CI, -4.44, -2.41; p < 0.001) and malondialdehyde (MDA) (β -0.30 μmol/L; 95% CI, -0.45, -0.15; p < 0.001), and increased HDL-cholesterol (β 2.62 mg/dL; 95% CI, 0.60, 4.63; p = 0.01) and total antioxidant capacity (TAC) levels (β 53.61 mmol/L; 95% CI, 4.65, 102.57; p = 0.03). Overall, magnesium and vitamin E co-supplementation for 12 weeks to patients with DFU had beneficial effects on ulcer size, glycemic control, triglycerides, LDL- and HDL-cholesterol, hs-CRP, TAC, and MDA levels.
本研究旨在确定镁和维生素 E 联合补充对糖尿病足溃疡(DFU)患者伤口愈合和代谢状态的影响。目前的随机、双盲、安慰剂对照试验在 57 名 3 级 DFU 患者中进行。参与者被随机分为两组,分别每天服用 250mg 氧化镁加 400IU 维生素 E(n=29)或安慰剂(n=28),共 12 周。与安慰剂相比,服用镁加维生素 E 补充剂可减少溃疡长度(β差异治疗组之间的结局指标平均值[0.56cm;95%CI,-0.92,-0.20;p=0.003])、宽度(β -0.35cm;95%CI,-0.64,-0.05;p=0.02)和深度(β -0.18cm;95%CI,-0.33,-0.02;p=0.02)。此外,联合补充可显著降低空腹血糖(β -13.41mg/dL;95%CI,-20.96,-5.86;p=0.001)、胰岛素(β -1.45μIU/ml;95%CI,-2.37,-0.52;p=0.003)、胰岛素抵抗(β -0.60;95%CI,-0.99,-0.20;p=0.003)和糖化血红蛋白(HbA1c)(β -0.32%;95%CI,-0.48,-0.16;p<0.003),并显著提高胰岛素敏感性(β 0.007;95%CI,0.003,0.01;p<0.001)与安慰剂相比。此外,与安慰剂相比,服用镁加维生素 E 补充剂可降低甘油三酯(β -10.08mg/dL;95%CI,-19.70,-0.46;p=0.04)、LDL-胆固醇(β -5.88mg/dL;95%CI,-11.42,-0.34;p=0.03)、高敏 C 反应蛋白(hs-CRP)(β -3.42mg/L;95%CI,-4.44,-2.41;p<0.001)和丙二醛(MDA)(β -0.30μmol/L;95%CI,-0.45,-0.15;p<0.001),并提高高密度脂蛋白胆固醇(β 2.62mg/dL;95%CI,0.60,4.63;p=0.01)和总抗氧化能力(TAC)水平(β 53.61mmol/L;95%CI,4.65,102.57;p=0.03)。总的来说,DFU 患者补充镁和维生素 E 联合治疗 12 周对溃疡大小、血糖控制、甘油三酯、LDL 和 HDL-胆固醇、hs-CRP、TAC 和 MDA 水平均有有益影响。